10X PBS pH 7.2
10X PBS pH 7.2 - Bottle
Datasheet is currently unavailable. Try again or CONTACT US
Datasheet

10X PBS pH 7.2

MB-008 MB-008-4000
1 L 4 x 1 L
FC, IF, Other
Have a Question? Ask a Specialist
$78.00 /Per Item
$137.00 /Per Item
Availability: Ships next business day Availability: Ships next business day
Shipping info:

$50.00 to US & Canada for most products. Final costs are calculated at checkout.

Description

Background

Phosphate buffered saline is suitable for multiple applications including biological diluent buffer for antibodies or other biologics. Also may be used as a wash buffer for immunological assays including western blot, immunohistochemistry, immunofluorescence microscopy, and ELISA. Other applications may require detergents or other additional components.

Application Note

This product is a concentrated stock solution and should be diluted appropriately with distilled, deionized water or equivalent to its final working concentration. 10X Phosphate Buffered Saline (PBS) consists of 0.2 M Potassium Phosphate, 1.5 M Sodium Chloride, pH 7.2 prepared in highly polished pharmaceutical grade water (WFI).

Purity/Specificity

10X PBS buffer was aseptically filtered through a Millipore 0.22 micron filter into clean, pre-sterilized containers. The product was tested on trypticase soy agar for 24 hours, 48 hours and 72 hours and was found to be negative for bacteria.

10X PBS pH 7.2 (0.2 M Potassium Phosphate 1.5 M Sodium Chloride) - MB-008
Phosphate buffered saline, Phosphate buffered solution, PBS, 10X PBS
FC, IF, Other
Liquid
10X N/A
See application note.
None
None
Ambient
Store container at room temperature (18° to 26° C) prior to opening. If desired, the solution may be stored at 4° C or less. Some salts may precipitate out of solution at lower temperature. Allow buffer to equilibrate to room temperature (18° to 26° C) to restore solubility of some salts.
Expiration date is six (6) months from date of opening.
Neidleman J et al. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. medRxiv. (2021)
Applications
Other
Jaeger N et al. Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions. Nat Commun. (2021)
Applications
FC, FACS, FLOW
Sahaf, B et al. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (2021)
Applications
Buffer
Henrick BM et al. Bifidobacteria-mediated immune system imprinting early in life. Cell. (2021)
Applications
FC, FACS, FLOW
Xie G et al. Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4+ T cell subsets in vivo. Cell Rep. (2021)
Applications
FC, FACS, FLOW
Vasudevan S et al. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. (2020)
Applications
FC, FACS, FLOW
Lakshmikanth T et al. Human immune system variation during 1 year. Cell Rep. (2020)
Applications
FC, FACS, FLOW
Sahaf B et al. High-parameter immune profiling with CyTOF. Methods Mol Biol. (2020)
Applications
FC, FACS, FLOW
Colomb F et al. Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy. Cell Rep. (2020)
Applications
FC, FACS, FLOW
Rodriguez L et al. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19 Cell Rep Med. (2020)
Applications
FC, FACS, FLOW
Neidleman J et al. SARS-CoV-2-specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential. Cell Rep Med. (2020)
Applications
FC, FACS, FLOW
Vendrame E et al. Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire. J Vis Exp. (2020)
Applications
FC, FACS, FLOW
Fenton TM et al. Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity. (2020)
Applications
FC, FACS, FLOW; IF, Confocal Microscopy
Waugh KA et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome. Cell Rep. (2019)
Applications
FC, FACS, FLOW
Cella M et al. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Nat Immunol. (2019)
Applications
FC, FACS, FLOW
Collins PL et al. Gene regulatory programs conferring phenotypic identities to human NK cells. Cell. (2019)
Applications
FC, FACS, FLOW
Cella, M et al. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Nature Immunology (2019)
Applications
Buffer; FC, FACS, FLOW
Olin A et al. Stereotypic immune system development in newborn children. Cell. (2018)
Applications
FC, FACS, FLOW
Leipold MD et al. Comparison of CyTOF assays across sites: Results of a six-center pilot study. J Immunol Methods. (2018)
Applications
FC, FACS, FLOW
Subrahmanyam PB et al. Cytof measurement of immunocompetence across major immune cell types. Curr Protoc Cytom. (2017)
Applications
FC, FACS, FLOW
Leipold MD et al. Phenotyping of live human PBMC using CyTOFTM mass cytometry. Bio Protoc. (2015)
Applications
FC, FACS, FLOW
Lin D et al. Intracellular cytokine staining on PBMCs Using CyTOF™ mass cytometry. Bio Protoc. (2015)
Applications
FC, FACS, FLOW
Fernandez R et al. Cytokine-stimulated phosphoflow of PBMC using CyTOF mass cytometry. Bio Protoc. (2015)
Applications
FC, FACS, FLOW
Fernandez, R et al. Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry. Bio-Protocol (2015)
Applications
FC, FACS, FLOW; Buffer
JENNIFER BERGER GENE EXPRESSION PATTERNS OF GAMMAHERPESVIRUSES. Olaf College (2012)
Applications
IF, Confocal Microscopy

Invalid lot number

If you need help finding your CofA, contact us

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.